|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Castellanos EH, Cardin DB and Berlin JD:
Treatment of early-stage pancreatic cancer. Oncology. 25:182–189.
2011.PubMed/NCBI
|
|
4
|
Semenza GL: Hypoxia-inducible factors:
Mediators of cancer progression and targets for cancer therapy.
Trends Pharmacol Sci. 33:207–214. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hoffmann AC, Mori R, Vallbohmer D,
Brabender J, Klein E, Drebber U, Baldus SE, Cooc J, Azuma M,
Metzger R, et al: High expression of HIF1α is a predictor of
clinical outcome in patients with pancreatic ductal adenocarcinomas
and correlated to PDGFA, VEGF, and bFGF. Neoplasia. 10:674–679.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao T, Gao S, Wang X, Liu J, Duan Y, Yuan
Z, Sheng J, Li S, Wang F, Yu M, et al: Hypoxia-inducible factor-1α
regulates chemotactic migration of pancreatic ductal adenocarcinoma
cells through directly transactivating the CX3CR1 gene. PLoS One.
7:e433992012. View Article : Google Scholar
|
|
7
|
Pouysségur J, Dayan F and Mazure NM:
Hypoxia signalling in cancer and approaches to enforce tumour
regression. Nature. 441:437–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu H, Liang X, Fang Y, Qin X, Zhang Y and
Liu J: Resveratrol inhibits hypoxia-induced metastasis potential
enhancement by restricting hypoxia-induced factor-1 alpha
expression in colon carcinoma cells. Biomed Pharmacother.
62:613–621. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Matsuo Y, Ding Q, Desaki R, Maemura K,
Mataki Y, Shinchi H, Natsugoe S and Takao S: Hypoxia inducible
factor-1 alpha plays a pivotal role in hepatic metastasis of
pancreatic cancer: An immunohistochemical study. J Hepatobiliary
Pancreat Sci. 21:105–112. 2014. View
Article : Google Scholar
|
|
10
|
Zhao X, Gao S, Ren H, Sun W, Zhang H, Sun
J, Yang S and Hao J: Hypoxia-inducible factor-1 promotes pancreatic
ductal adenocarcinoma invasion and metastasis by activating
transcription of the actin-bundling protein fascin. Cancer Res.
74:2455–2464. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lei J, Ma J, Ma Q, Li X, Liu H, Xu Q, Duan
W, Sun Q, Xu J, Wu Z, et al: Hedgehog signaling regulates hypoxia
induced epithelial to mesenchymal transition and invasion in
pancreatic cancer cells via a ligand-independent manner. Mol
Cancer. 12:662013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McMahon AP, Ingham PW and Tabin CJ:
Developmental roles and clinical significance of hedgehog
signaling. Curr Top Dev Biol. 53:1–114. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nguyen NT, Lin DP, Yen SY, Tseng JK,
Chuang JF, Chen BY, Lin TA, Chang HH and Ju JC: Sonic hedgehog
promotes porcine oocyte maturation and early embryo development.
Reprod Fertil Dev. 21:805–815. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Olive KP, Jacobetz MA, Davidson CJ,
Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA,
Caldwell ME, Allard D, et al: Inhibition of Hedgehog signaling
enhances delivery of chemotherapy in a mouse model of pancreatic
cancer. Science. 324:1457–1461. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li W, Cao L, Han L, Xu Q and Ma Q:
Superoxide dismutase promotes the epithelial-mesenchymal transition
of pancreatic cancer cells via activation of the
H2O2/ERK/NF-κB axis. Int J Oncol.
46:2613–2620. 2015.
|
|
16
|
Li W, Ma Q, Li J, Guo K, Liu H, Han L and
Ma G: Hyperglycemia enhances the invasive and migratory activity of
pancreatic cancer cells via hydrogen peroxide. Oncol Rep.
25:1279–1287. 2011.PubMed/NCBI
|
|
17
|
Lei J, Huo X, Duan W, Xu Q, Li R, Ma J, Li
X, Han L, Li W, Sun H, et al: α-Mangostin inhibits hypoxia-driven
ROS-induced PSC activation and pancreatic cancer cell invasion.
Cancer Lett. 347:129–138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen BY, Kuo CH, Liu YC, Ye LY, Chen JH
and Shieh CJ: Ultrasonic-assisted extraction of the botanical
dietary supplement resveratrol and other constituents of Polygonum
cuspidatum. J Nat Prod. 75:1810–1813. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Albani D, Polito L, Signorini A and
Forloni G: Neuroprotective properties of resveratrol in different
neurodegenerative disorders. Biofactors. 36:370–376. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fulda S: Resveratrol and derivatives for
the prevention and treatment of cancer. Drug Discov Today.
15:757–765. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jha RK, Ma Q, Sha H and Palikhe M:
Emerging role of resveratrol in the treatment of severe acute
pancreatitis. Front Biosci. 2:168–175. 2010. View
Article : Google Scholar
|
|
22
|
Li W, Ma J, Ma Q, Li B, Han L, Liu J, Xu
Q, Duan W, Yu S, Wang F, et al: Resveratrol inhibits the
epithelial-mesenchymal transition of pancreatic cancer cells via
suppression of the PI-3K/Akt/NF-κB pathway. Curr Med Chem.
20:4185–4194. 2013. View Article : Google Scholar
|
|
23
|
Qin Y, Ma Z, Dang X, Li W and Ma Q: Effect
of resveratrol on proliferation and apoptosis of human pancreatic
cancer MIA PaCa-2 cells may involve inhibition of the Hedgehog
signaling pathway. Mol Med Rep. 10:2563–2567. 2014.PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔC T method. Methods. 25:402–408.
2001. View Article : Google Scholar
|
|
25
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Spivak-Kroizman TR, Hostetter G, Posner R,
Aziz M, Hu C, Demeure MJ, Von Hoff D, Hingorani SR, Palculict TB,
Izzo J, et al: Hypoxia triggers hedgehog-mediated tumor-stromal
interactions in pancreatic cancer. Cancer Res. 73:3235–3247. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luoto KR, Kumareswaran R and Bristow RG:
Tumor hypoxia as a driving force in genetic instability. Genome
Integr. 4:52013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ye LY, Zhang Q, Bai XL, Pankaj P, Hu QD
and Liang TB: Hypoxia-inducible factor 1α expression and its
clinical significance in pancreatic cancer: A meta-analysis.
Pancreatology. 14:391–397. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bijlsma MF, Groot AP, Oduro JP, Franken
RJ, Schoenmakers SH, Peppelenbosch MP and Spek CA: Hypoxia induces
a hedgehog response mediated by HIF-1alpha. J Cell Mol Med.
13:2053–2060. 2009. View Article : Google Scholar
|
|
30
|
Nishikawa M, Hashida M and Takakura Y:
Catalase delivery for inhibiting ROS-mediated tissue injury and
tumor metastasis. Adv Drug Deliv Rev. 61:319–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu Q, Zong L, Chen X, Jiang Z, Nan L, Li
J, Duan W, Lei J, Zhang L, Ma J, et al: Resveratrol in the
treatment of pancreatic cancer. Ann NY Acad Sci. 1348:10–19. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mitani T, Harada N, Tanimori S, Nakano Y,
Inui H and Yamaji R: Resveratrol inhibits hypoxia-inducible
factor-1α-mediated androgen receptor signaling and represses tumor
progression in castration-resistant prostate cancer. J Nutr Sci
Vitaminol. 60:276–282. 2014. View Article : Google Scholar
|
|
33
|
Mitani T, Ito Y, Harada N, Nakano Y, Inui
H, Ashida H and Yamaji R: Resveratrol reduces the hypoxia-induced
resistance to doxorubicin in breast cancer cells. J Nutr Sci
Vitaminol. 60:122–128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ji Q, Liu X, Fu X, Zhang L, Sui H, Zhou L,
Sun J, Cai J, Qin J, Ren J, et al: Resveratrol inhibits invasion
and metastasis of colorectal cancer cells via MALAT1 mediated
Wnt/β-catenin signal pathway. PLoS One. 8:e787002013. View Article : Google Scholar
|
|
35
|
Sun L, Li H, Chen J, Dehennaut V, Zhao Y,
Yang Y, Iwasaki Y, Kahn-Perles B, Leprince D, Chen Q, et al: A
SUMOylation-dependent pathway regulates SIRT1 transcription and
lung cancer metastasis. J Natl Cancer Inst. 105:887–898. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang Q, Tang X, Lu QY, Zhang ZF, Brown J
and Le AD: Resveratrol inhibits hypoxia-induced accumulation of
hypoxia-inducible factor-1alpha and VEGF expression in human tongue
squamous cell carcinoma and hepatoma cells. Mol Cancer Ther.
4:1465–1474. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gao Q, Yuan Y, Gan HZ and Peng Q:
Resveratrol inhibits the hedgehog signaling pathway and
epithelial-mesenchymal transition and suppresses gastric cancer
invasion and metastasis. Oncol Lett. 9:2381–2387. 2015.PubMed/NCBI
|
|
38
|
Su YC, Li SC, Wu YC, Wang LM, Chao KS and
Liao HF: Resveratrol downregulates interleukin-6-stimulated sonic
hedgehog signaling in human acute myeloid leukemia. Evid Based
Complement Alternat Med. 2013:5474302013. View Article : Google Scholar : PubMed/NCBI
|
